|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Molecular and Life Sciences, Pohang University of Science and Technology, Pohang, Kyungbuk, Korea, Republic of
* To whom correspondence should be addressed. E-mail: gykoh{at}postech.ac.kr.
To clarify the role of caveolae in vascular endothelial growth factor (VEGF)/VEGF receptor-2 (VEGFR-2)-mediated signaling cascades, primary cultured human umbilical
vein endothelial cells (HUVECs) were fractionated to isolate caveolae-enriched cell membranes. Interestingly, VEGFR-2, phospholipase D2 (PLD2), and Ras were enriched
in caveolae-enriched fractions. Moreover, VEGF increased PLD activity in a time- and dose-dependent manner in HUVECs, while a ligand specific for VEGFR-1, placenta
growth factor, did not change PLD activity. A PLD inhibitor, 1-butanol almost completely suppressed VEGF-induced ERK phosphorylation and cellular proliferation,
while the negative control for 1-butanol, 3-butanol, did not produce significant changes. Addition of phosphatidic acid negated the 1-butanol-induced suppression.
Pharmacological analyses using several inhibitors indicated that protein kinase C-
(PKC-
) regulates the VEGF-induced activation of PLD/ERK. Thus, PLD2 could be involved in MEK/ERK signaling cascades that are induced by the VEGF/VEGFR- 2/PKC-
pathway in endothelial cells. Pretreatment with the cholesterol depletion agent
methyl-
-cyclodextrin (M
CD) almost completely disassembled caveolar structures, while addition of cholesterol to M
CD-treated cells restored caveolar structures. Pretreatment with M
CD largely abolished phosphorylation of MEK/ERK by VEGF, while addition of cholesterol restored VEGF-induced MEK/ERK phosphorylations. These results indicate that intact caveolae are required for the VEGF/VEGFR-2 mediated MEK/ERK signaling cascade.
This article has been cited by other articles:
![]() |
P. Mukherjee, A. C. Faber, L. M. Shelton, R. C. Baek, T. C. Chiles, and T. N. Seyfried Thematic Review Series: Sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a J. Lipid Res., May 1, 2008; 49(5): 929 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gosens, G. Dueck, W. T. Gerthoffer, H. Unruh, J. Zaagsma, H. Meurs, and A. J. Halayko p42/p44 MAP kinase activation is localized to caveolae-free membrane domains in airway smooth muscle Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1163 - L1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, D. B. Jump, W. J. Esselman, and J. V. Busik Inhibition of Cytokine Signaling in Human Retinal Endothelial Cells through Modification of Caveolae/Lipid Rafts by Docosahexaenoic Acid Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 18 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. S. Sobke, D. Selimovic, V. Orlova, M. Hassan, T. Chavakis, A. N. Athanasopoulos, U. Schubert, M. Hussain, G. Thiel, K. T. Preissner, et al. The extracellular adherence protein from Staphylococcus aureus abrogates angiogenic responses of endothelial cells by blocking Ras activation FASEB J, December 1, 2006; 20(14): 2621 - 2623. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ballard-Croft, A. C. Locklar, G. Kristo, and R. D. Lasley Regional myocardial ischemia-induced activation of MAPKs is associated with subcellular redistribution of caveolin and cholesterol Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H658 - H667. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Li, K.-R. Chiou, A. Bugayenko, K. Irani, and D. A. Kass Reduced Wall Compliance Suppresses Akt-Dependent Apoptosis Protection Stimulated by Pulse Perfusion Circ. Res., September 16, 2005; 97(6): 587 - 595. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |